questionText: To ask the Secretary of State for Health and Social Care, what progress he has made on increasing the availability of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.
answerText: As a result of intensive work, some issues with attention deficit hyperactivity disorder medicines have resolved. All strengths of lisdexamfetamine, atomoxetine capsules, atomoxetine oral solution, and guanfacine prolonged-release tablets are now availabl...
heading: Methylphenidate and Pancreatic Enzyme Replacement Therapy